# A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection

> **NCT00784368** · PHASE3 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 55 (actual)

## Conditions studied

- Mycoses
- Candidiasis
- Aspergillosis
- Cryptococcosis
- Blastomycosis
- Histoplasmosis
- Neutropenia

## Interventions

- **DRUG:** ITCZ Oral Solution
- **DRUG:** ITCZ-IV

## Key facts

- **NCT ID:** NCT00784368
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784368, "A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT00784368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*